New community effort aims to slash HPV risk in nigerian families

NCT ID NCT06728085

Ongoing Prevention Sponsor: Washington University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a community-driven campaign to increase HPV prevention among mother-daughter pairs in Nigeria. About 1,838 participants will take part in events and surveys. The goal is to get more girls vaccinated against HPV and more mothers to self-test for the virus, which can lead to cervical cancer.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: community engagement campaign (behavioural intervention)
What this could lead to: If successful, this approach could increase HPV vaccination rates in girls and HPV self-testing in mothers, helping prevent cervical cancer in communities.
What could go wrong: This is a pragmatic trial in Nigeria, so results may not apply elsewhere. The campaign's success depends on community participation, and the study does not test a new drug or vaccine.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HPV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cervical cancer prevention target human papilloma virus infection prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HPV

Contacts and locations

Locations

Nigerian Institute of Medical Research

Yaba, Lagos, Nigeria

More trials for these conditions

Other studies related to the condition(s) this trial covers.